Allogene Therapeutics News

Allogene Therapeutics | DEFA14A: Others

Apr 23 16:38 ET

Allogene Therapeutics | DEF 14A: Definitive information statements

Apr 23 16:38 ET

Allogene Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 14 17:31 ET

Allogene Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Mar 14 17:25 ET

Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

Mar 14 16:17 ET

Allogene Therapeutics | 8-K: Current report

Feb 16 08:31 ET

Allogene Therapeutics | 8-K: Current report

Jan 31 13:48 ET

Allogene Therapeutics | 8-K: Current report

Jan 5 00:00 ET

Allogene Therapeutics | 8-K: Current report

Dec 19, 2023 15:46 ET

Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update

Nov 2, 2023 16:03 ET

Allogene Therapeutics | 8-K/A: Current report (Amendment)

Oct 17, 2023 16:34 ET

Allogene Therapeutics | 8-K: Current report

Oct 16, 2023 08:31 ET

Allogene Therapeutics | 8-K: Allogene Therapeutics Reports Second Quarter 2023 Financial Results and Business Update

Aug 2, 2023 16:04 ET

Allogene Therapeutics | 8-K: Current report

Jun 21, 2023 16:05 ET

Allogene Therapeutics | 8-K: Current report

Jun 15, 2023 16:08 ET

Allogene Therapeutics | 8-K: Current report

Jun 14, 2023 08:04 ET

Allogene Therapeutics | 8-K: Current report

Jun 7, 2023 16:16 ET

Allogene Therapeutics | 8-K: Allogene Therapeutics Reports First Quarter 2023 Financial Results and Business Update

May 3, 2023 16:05 ET

Allogene Therapeutics | DEFA14A: Others

Apr 24, 2023 16:09 ET

Allogene Therapeutics | DEF 14A: Definitive proxy statements

Apr 24, 2023 16:06 ET